Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
GALA RENEE D (CIK 1607737) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-10). Recent activity: Sell JAZZ (1,967 shares), Sell JAZZ (2,000 shares), Sell JAZZ (4,835 shares), Sell JAZZ (600 shares), Buy DXCM (5,605 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 1,967 | $485,475 |
| 2026-09-10 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 2,000 | $486,060 |
| 2026-07-02 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 4,835 | $1.1M |
| 2026-06-05 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 600 | $0 |
| 2026-06-01 | DEXCOM INC (DXCM) | Director | Buy | 5,605 | $0 |
| 2026-03-09 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 7,065 | $1.3M |
| 2026-03-02 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Buy | 44,465 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Buy | 12,741 | $0 |
| 2026-01-21 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 5,371 | $919,300 |
| 2025-12-09 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Sell | 80 | $13,353 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | President & CEO | Buy | 18,808 | $0 |
| 2025-07-07 | DEXCOM INC (DXCM) | Director | Buy | 1,161 | $0 |
| 2025-05-12 | DEXCOM INC (DXCM) | Director | Buy | 5,074 | $0 |
Source: SEC Form 4 filings · as of 2026-09-10